Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2004
12/23/2004US20040258614 Microparticles for microarterial imaging and radiotherapy
12/23/2004CA2529496A1 Anti-cd74 immunoconjugates and methods
12/23/2004CA2529486A1 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
12/23/2004CA2528869A1 Directing cells to target tissues or organs
12/23/2004CA2528359A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
12/23/2004CA2494704A1 Radioactively labelled amino acid analogues, their preparation and use
12/22/2004EP1489097A1 Inhibitors of human plasmin derived from kunitz domains and nucleic acids encoding the same
12/22/2004EP1487879A2 Bispecific antibody point mutations for enhancing rate of clearance
12/22/2004EP1487487A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
12/22/2004CN1181096C Cyclic hexapeptide somatostatin analogues
12/21/2004US6833448 Annexin derivatives with endogenous chelation sites
12/21/2004US6833376 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal
12/16/2004WO2004109181A2 Device having a location for holding hyperpolarized inert gas
12/16/2004WO2004108747A2 Lectin conjugates
12/16/2004WO2004091444A3 Implantable medical device comprising therapeutic agents with different diffusion rates
12/16/2004WO2004076449A3 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
12/16/2004WO2004061423A3 Compositions and methods for diagnosing and treating colon cancers
12/16/2004WO2004010951A3 Method of treating tumors
12/16/2004WO2003104799A3 Imaging method and device for carrying out said method
12/16/2004WO2003035011A8 Multidrug multiligand conjugates for targeted drug delivery
12/16/2004US20040254339 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours
12/16/2004US20040253653 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy
12/16/2004US20040253225 Gastrin releasing peptide compounds
12/16/2004US20040253184 Lipid containing hydrophilic head group comprising lanthanide-diethylenetriamine pentaacetic acid chelate, linker group is selected from polyethylene glycol, propylene glycol, and polyglycines; imaging enhancement
12/16/2004US20040253177 Fatty acid derivatives; tissue-targeted therapy; tomography; cardiovascular disorders; liver disorders; kits
12/15/2004EP1486785A1 Test agents for evaluating pharmacological effect of drug, and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or produrgs thereof
12/15/2004EP1486509A2 Radiolabeled annexin-galactose cluster conjugates
12/15/2004EP1486216A1 Method of encapsulating metal complex within liposomes
12/15/2004EP1485476A2 Dimeric tf antagonist
12/15/2004EP1485160A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
12/15/2004EP1485076A1 Therapeutic methods for acute myeloid leukemia
12/15/2004EP1485075A2 Mhc-peptide complex binding ligands
12/14/2004US6831269 Lesion phantoms with no inner cold encapsulation
12/14/2004CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/14/2004CA2180555C Radiolabeled annexins
12/09/2004WO2004105802A1 Tracer for medical imaging
12/09/2004WO2004079751A3 Method for producing actinium-225
12/09/2004WO2003093478A9 Immunoconjugates for the treatment of tumours
12/09/2004US20040249130 Aptamer-toxin molecules and methods for using same
12/09/2004US20040249124 Viral protein for use in generation of immunogllobulins to prevent lymphadenopathy associated viral infections; immunotherapy; viricides
12/09/2004US20040248880 Radioligands; diagnosing anxiety, depression, central nervous system disorders; tomography
12/09/2004US20040248783 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/09/2004US20040247523 Diagnosing and localizing sites of inflammation and perfusion abnormalities (e.g. reperfusion injury, vulnerable plaque, bacterial endocarditis or cardiac transplant rejection) in a single dual isotope imaging procedure, particularly CT imaging, ultrasound, or scintigraphy.
12/08/2004EP1484339A2 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
12/08/2004EP1483399A2 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
12/08/2004EP1483297A2 Antibodies derived from anti ed-b l19 and targeting tumor vasculature
12/08/2004EP1483295A2 Rs7 antibodies
12/08/2004EP1483290A2 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/08/2004EP1483262A1 Coumarines useful as biomarkers
12/08/2004EP1482988A1 METHOD OF RADIO−LABELLING BIOMOLECULES
12/08/2004EP1482985A2 Technetium-dipyridine complexes, and methods of use thereof
12/08/2004EP1482981A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
12/08/2004EP1482795A1 New immunoeffector compounds
12/07/2004US6828299 Polyhydroxy glycopeptide derivatives
12/07/2004US6827925 Specific binding proteins including antibodies which bind to the necrotic center of tumors, and uses thereof
12/07/2004CA2070961C Thiol-reactive maleimido-based radiolabeling reagents
12/02/2004US20040243225 Controlled release of peptide active materials; vapor deposition
12/02/2004US20040242953 Endocurietherapy
12/02/2004US20040242852 Bifunctional chelating agent for actinium
12/02/2004US20040242842 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
12/02/2004US20040242582 diagnostic agent comprising a contrast agent for use in medical imaging conjugated with non-peptide folic acid analog
12/02/2004US20040241248 Crosslinking the carboxylic acid groups in a glycosaiminoglycan with a primary amine in a lipid to form particles that can be used to encapsulate various drugs, especially chemotherapeutic agents
12/02/2004US20040241172 Pretargeting methods and compounds
12/02/2004US20040241158 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis
12/02/2004US20040241095 Complex containing cyanine dyes; supplying to target tumor cells
12/02/2004US20040241090 Compounds, compositions and methods for medical imaging of neuropsychiatric disorders
12/02/2004US20040241088 Method for evaluating the efficacy of certain cancer treatments
12/01/2004EP1481633A1 Method for detecting a substance of metabolism of a living body and apparatus therefor
12/01/2004EP1125304B1 Integrated radiation shied
12/01/2004CN1551886A Specific human antibodies for selective cancer therapy
12/01/2004CN1177806C Diagnostic imaging contrast agents with extended blood retention
11/2004
11/30/2004US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004US6825008 Expressed ligand—vascular intercellular signalling molecule
11/30/2004US6824760 Imaging agents, precursors thereof and methods of manufacture
11/30/2004US6824759 Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
11/25/2004WO2004102192A1 A non-invasive assay for the assessment of functioning and/or structure of the gut
11/25/2004WO2004101737A2 A novel adjuvant capable of specifically activating the adaptive immune response
11/25/2004WO2004100983A2 Treatment of lupus targeting the macrophages or the folate receptor
11/25/2004WO2004100769A2 Methods for using gadolinium as a contrast media
11/25/2004WO2004065423A3 Recognition molecules for the treatment and detection of tumours
11/25/2004US20040236085 Solid-phase nucleophilic fluorination
11/25/2004US20040236076 Polyclonal IgY compound from eggs of transgenic SPF-chickens with constant regions of human IgG and additionally consist of at least one signal and/or active agent and/or booster molecule; for treating noninfectious inflammations, infectious diseases, clotting disorders, autoimmune diseases and cancer
11/25/2004US20040235065 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/25/2004US20040234528 Binding, neutralization respiratory syncytial virus antigen
11/25/2004US20040234450 Compositions, methods, apparatuses, and systems for singlet oxygen delivery
11/25/2004DE10320552A1 Apparatus marking pharmaceutical substances with fluorine isotope, preparatory to positron-emission tomography, locates anion exchanger within measurement chamber
11/25/2004CA2526031A1 Sugar breath test and sugar absorption test for assessment of gut function
11/25/2004CA2525369A1 Methods for using gadolinium as a contrast media
11/24/2004EP1479399A1 Method of loading a radioelement generator with mother radionuclide
11/24/2004EP1479084A1 Flow cell, method for separating carrier-free radionuclides, and the radiochemical reaction thereof
11/24/2004EP1478407A1 Use of 13c labelled substance for measuring lung function
11/24/2004EP1478361A2 Arylsulfone derivatives
11/24/2004EP1478276A2 Novel targeted compositions for diagnostic and therapeutic use
11/24/2004EP1176988B1 Radioactive cisplatin in the treatment of cancer
11/24/2004CN1549731A Stilbene derivatives and their use for binding and imaging amyloid plaques
11/24/2004CN1548159A Composite magnetic material and its use in treating cancer
11/23/2004US6821506 Site specific binding system, imaging compositions and methods
11/23/2004CA2265587C Cyanidin compositions and therapeutic and diagnostic uses therefor
11/23/2004CA2134239C Pretargeting methods and compounds
11/18/2004WO2004100490A2 Device and method for the fluorination of nucleophiles